Nanobody - MDPI
The incorporation of nanobodies as target domains improves their therapeutic use due to their lower molecular size and binding features. The ...
Therapeutic Nanobodies Targeting Cell Plasma Membrane ...& Melero, J. A. Generation and characterization of ALX-0171, a potent novel therapeutic nanobody for the treatment of respiratory syncytial virus infection. A bivalent spike-targeting nanobody with anti-sarbecovirus activityOzoralizumab, a bi-nanobody-based BsAb featuring two anti-TNF? nanobodies and one anti-HAS nanobody, is currently undergoing phase 2 clinical. VHH Trimer Paper_mAbs_submission_v3.docx - bioRxivThis bispecific nanobody prevents SARS-CoV-2 from infecting host cells through ACE2, and blocks the excessive inflammatory response triggered by ...
Autres Cours:
